World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
25375
World Ranking
14201
National Ranking
156

Finn Gustafsson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Finn Gustafsson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 598 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Finn Gustafsson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Finn Gustafsson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Finn Gustafsson is affiliated with the University of Copenhagen in Denmark and has made significant contributions in the field of medicine, with a primary focus on cardiology and cardiovascular medicine. Their research spans several subfields, including surgery, biomedical engineering, endocrinology, diabetes and metabolism, and molecular biology.

The scientific work of Finn Gustafsson extensively covers topics such as mechanical circulatory support devices, heart failure treatment and management, cardiovascular function and risk factors, cardiac structural anomalies and repair, cardiac pacing and defibrillation studies, transplantation methods and outcomes, and diabetes treatment and management.

Frequent coauthors collaborating with Finn Gustafsson include Lars Køber, Morten Schou, Caroline Kistorp, Kasper Rossing, and Marco Metra, reflecting ongoing partnerships within the cardiovascular research community.

Finn Gustafsson regularly publishes in prominent journals related to cardiovascular science and heart failure treatment. The most frequent publication venues are:

  • European Journal of Heart Failure
  • The Journal of Heart and Lung Transplantation
  • ESC Heart Failure
  • European Heart Journal
  • Circulation Heart Failure

Several recent papers illustrate the scope and impact of Finn Gustafsson's research efforts:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2021, European Heart Journal
  • Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment, 2020, Nature Reviews Cardiology
  • Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis, 2023, New England Journal of Medicine
  • Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction, 2021, JAMA Cardiology
  • Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC, 2023, European Journal of Heart Failure

Best Publications

  • Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

    Lars Køber;Jens J. Thune;Jens J. Thune;Jens C. Nielsen;Jens C. Nielsen;Jens Haarbo;Jens Haarbo

  • Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure

    Caroline Kistorp;Jens Faber;Søren Galatius;Finn Gustafsson

  • Advanced heart failure : a position statement of the Heart Failure Association of the European Society of Cardiology

    María Generosa Crespo-Leiro;Marco Metra;Lars H. Lund;Davor Milicic

  • N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults

    Caroline Kistorp;Ilan Raymond;Frants Pedersen;Finn Gustafsson

  • Severely Impaired von Willebrand Factor-Dependent Platelet Aggregation in Patients With a Continuous-Flow Left Ventricular Assist Device (HeartMate II)

    Jolanta Klovaite;Finn Gustafsson;Svend A. Mortensen;Kåre Sander

  • A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial

    Gerd Hasenfuß;Chris Hayward;Dan Burkhoff;Frank E Silvestry

  • Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.

    Finn Gustafsson;Joseph G. Rogers

  • Diagnostic and Prognostic Performance of N-Terminal ProBNP in Primary Care Patients With Suspected Heart Failure

    Finn Gustafsson;Frank Steensgaard-Hansen;Jørn Badskjær;Allan H. Poulsen

  • Incidence of cancer in patients with chronic heart failure: a long-term follow-up study

    Ann Banke;Morten Schou;Lars Videbaek;Jacob E Møller

  • Congestion in Heart Failure: A Contemporary Look at Physiology, Diagnosis and Treatment

    Eva M Boorsma;Jozine M Ter Maaten;Kevin Damman;Wilfried Dinh

  • N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome

    Michael H. Olsen;Tine W. Hansen;Marina K. Christensen;Finn Gustafsson

  • Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function

    Finn Gustafsson;Christian Torp-Pedersen;Bente Brendorp;Marie Seibaek

  • Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function.

    Finn Gustafsson;Charlotte B Kragelund;Christian Torp-Pedersen;Marie Seibaek

  • Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction Insights From the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study

    Patrick Rossignol;John G.F. Cleland;Sunil Bhandari;Stephane Tala

  • Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction

    Ida Gustafsson;Christian Torp-Pedersen;Lars Køber;Finn Gustafsson

  • Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).

    Mads Andersen;Regitze Videbæk;Søren Boesgaard;Kåre Sander

  • Heart failure clinics and outpatient management: review of the evidence and call for quality assurance.

    Finn Gustafsson;J. Malcolm O. Arnold

  • Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.

    Marie Bayer Elming;Jens C Nielsen;Jens Haarbo;Lars Videbæk

  • How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure

    Morten Svensson;Finn Gustafsson;SØren Galatius;Per R Hildebrandt

  • Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects: Insights From an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) Substudy

    Patrick Rossignol;Joël Ménard;Joël Ménard;Renaud Fay;Finn Gustafsson

Frequent Co-Authors

Christian Torp-Pedersen
Christian Torp-Pedersen Aalborg University
Lars Køber
Lars Køber Copenhagen University Hospital
Jesper Hastrup Svendsen
Jesper Hastrup Svendsen Copenhagen University Hospital
Christian Hassager
Christian Hassager University of Copenhagen
Jens Cosedis Nielsen
Jens Cosedis Nielsen Aarhus University Hospital
Jens Nielsen
Jens Nielsen Chalmers University of Technology
Gerasimos Filippatos
Gerasimos Filippatos National and Kapodistrian University of Athens
Allan Flyvbjerg
Allan Flyvbjerg Steno Diabetes Center
Jens Christian Refsgaard
Jens Christian Refsgaard Geological Survey of Denmark and Greenland
Dan Atar
Dan Atar University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens many related paths beyond the traditional MD. For those interested in nursing or allied healthcare professions, online degrees offer flexibility, affordability, and accelerated options.

Pursuing advanced nursing credentials is increasingly popular. Many professionals opt for online nursing PhD programs to boost their careers in leadership, education, or research. If you’re a registered nurse aiming to enhance your qualifications quickly and affordably, you can explore some of the cheapest RN to BSN online programs to upskill while continuing to work.

For those with a non-nursing bachelor’s degree considering a career change, direct entry MSN online programs can provide a fast track to becoming a nurse with a master’s degree.

If you’re just starting out and looking for more accessible options to begin your journey, check out the easiest nursing schools to get into. Each of these pathways offers unique advantages for building a meaningful healthcare career.

Best Scientists Citing Finn Gustafsson

Trending Scientists

Recently Published Articles